
C2PO News
Research conducted at USP indicates that SGLT2i may be used as an adjuvant in cancer treatments
The study was published in BMC Cancer.

The study was published in BMC Cancer.

This content is in Portuguese.

This content is in Portuguese.

This content is in Portuguese.

This content is in Portuguese.

Applications are open until May 23, 2025.

Episode discusses cervical cancer, HPV, and vaccines. Available in Portuguese.

This content is in Portuguese.

This content is in Portuguese.

The preliminary results of the call were published by the National Research and Development Council (CNPq) on March 20th; a total 37 projects were approved in São Paulo

This content is in Portuguese.